CRIP1 is negatively correlated with Th2 and natural killer cells in patients with ovarian cancer, suggesting that patients with tumors having high CRIP1 expression may have immunosuppression; gene enrichment shows that it may be related to abnormal activation of JAK/STAT signaling pathway. Here, CRIP1 is linked to ovarian carcinoma.